When you think biotech stocks, you should be thinking groundbreaking… and lucrative.
If you’re a healthcare investor, no doubt you recall the drubbing of the biotechnology sector earlier this year.
That’s when indices like the iShares NASDAQ Biotechnology Index and the S&P Biotech ETF lost at least one-quarter of their values.
Though the industry hasn’t yet recovered, biotech is poised for a rebound.
These 5 companies lead the rally with important and promising products in their pipelines.